In Reply: There is no evidence that guidelines or training improve EMR note quality. In the absence of evidence, only expert opinion remains. It is my opinion as a medical educator, experienced if not expert, that training has minimal lasting impact.
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RESEARCH LETTER
Pancreas Organ Weight in Individuals With Disease-Associated Autoantibodies at Risk for Type 1 Diabetes
To the Editor: Autopsy and imaging studies suggest that human pancreata from adults with type 1 diabetes (T1D) are smaller and weigh less than those without the disease.
1,2 However, it is unknown when pancreatic atrophy begins in T1D.
Therefore, we examined pancreas weight early in the natural history of T1D from at-risk individuals without diabetes but with disease-associated autoantibodies, obtained through the Network for Pancreatic Organ Donors with Diabetes program. 3 All donors were identified by organ procurement organizations that coordinate organ and tissue donations for clinical transplantation or research.
Methods. Between October 16, 2006, and April 27, 2012, 193 pancreata were recovered from cadaveric multiorgan donors in the United States and considered for the study following written informed research consent from the next of kin. Study procedures were in accordance with the Declaration of Helsinki and the University of Florida institutional review board, and were detailed previously. 3 Information on demographics and medical history were obtained from chart review or through a data-sharing agree- 3 Prior to organ recovery, initial screening for autoantibodies to glutamic acid decarboxylase 65 and insulinoma-associated 2ic was performed. Following receipt of the pancreas, confirmatory testing was completed and also included autoantibodies to insulin and zinc transporter 8 antigens. T1D was confirmed by laboratory markers and medical chart review.
We included 23 controls without T1D, 8 T1D-free single islet autoantibody-positive donors, and 20 T1D cases. Cases were excluded with damaged pancreata (n = 17); missing organ weight (n = 26) or confirmatory autoantibody testing results (n = 10); other diseases or unresolved medical history (n = 34); unconfirmed (n = 1) or with multiple (n = 3) autoantibodies; pancreatitis (n = 20) or pancreatic endocrine tumor (n = 1); and donors aged 18 years or younger (n=30).
The primary outcome variable was pancreas weight of donors in the 3 groups, examined using a general linear model to account for the influence of covariates on the end point (TABLE) . Only age and body mass index (BMI) were retained in the final model. Other variables were not included due to multicollinearity, nonsignificance, or lack of previous evidence for an association.
All P values are unadjusted, 2-tailed, and statistically significant if less than .05, unless otherwise noted. Statistical analysis was performed using SAS software version 9.2 (SAS Institute Inc). The boxes represent the mid 50% of the data, the line within box represents the group mean value adjusted for age and body mass index. The high and low whiskers represent the 95th and 5th percentiles, respectively. The filled black circles represent outliers. Using the t test, the comparison between donors without diabetes and those positive for a single autoantibody only yielded a P value of .02; and for the comparison between donors without diabetes and those with type 1 diabetes yielded a P value of less than .001. A comparison between the donors positive for a single autoantibody only and those with type 1 diabetes was not performed. Statistical significance was indicated at a Bonferroni-corrected nominal ␣ level of .025. Of note, although age and body mass index were poorly correlated with pancreas weight and failed to meet one of the assumptions of analysis of covariance, both were included into the final model because linear models that included age or body mass index by disease status group interaction terms showed that the interaction was not statistically significant. Abbreviation: NA, not applicable. a Collinear terms assessed using pairwise correlations for all continuous variables defined as any 2 factors with a P value of less than .05 and a r value of 0.80 or greater. Multicollinearity was defined when the variance inflation factor was greater than 1 as previously described. 4 Multiclass categorical variables were independently screened for collinearity using a 2 test. Interaction terms included both age and body mass index by disease status group. For all remaining candidate covariates considered in the final model, the assumptions of analysis of covariance were evaluated as described elsewhere. Results. Of the 51 donors, 46 were classified as brain dead and 5 as nonheart beating. Baseline characteristics were similar across groups, with the exception of all diabetes-related variables, reflecting criteria used to categorize the donors (Table) . Most donors received cardiovascular drugs prior to death, but there was variation between the 3 disease status groups (Table) .
Differences existed in the mean pancreas weight of individuals stratified by disease status and adjusted for age and BMI (FIGURE). The mean weight of pancreata from those without diabetes (controls) was 81.4 g (95% CI, 73.0-89.8 g) compared with 61.3 g (95% CI, 46.8 g-75.8 g; P = .02) from the group positive for a single autoantibody only and 44.9 g (95% CI, 36.0 g-53.9 g; PϽ.001) from the T1D group.
Comment. In this study, the weight of pancreata in individuals without T1D, but with serum markers that potentially precede the clinical manifestations, as well as in individuals with T1D, was less than in controls. This suggests that early atrophy of the organ may be an important subclinical feature of T1D pathogenesis.
Limitations exist due to the small sample size and expected low incidence of subsequent T1D in single autoantibody-positive individuals. 6 Additionally, functional assessment of pancreata was not possible, precluding evaluation of both the exocrine and endocrine compartments of the gland. In this data set, there is no evidence that cause of death or organ retrieval procedures affected organ weight.
Future studies should include validation and analysis of the potential mechanisms underlying this observation to understand whether early pancreatic atrophy contributes to the pathogenesis of T1D.
